Comparison of the Effects of Sevoflurane and Midazolam Used for the Maintenance of Anaesthesia on the Levels of Postoperative Cardiac Troponin I in Pediatric Cardiac Surgery
NCT ID: NCT01548859
Last Updated: 2012-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
50 participants
INTERVENTIONAL
2011-07-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myocardial Protection and Anesthetic Agents
NCT02405689
Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease
NCT04125550
Effect of Sevoflurane in Postoperative Troponin I Levels in Children Undergoing Congenital Heart Defects Surgery
NCT03630796
The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery
NCT01450956
Three Anaesthesic Method in Electroconvulsive Theraphy
NCT01759589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midazolam
Used for maintenance anaesthesia (0.2 mg/kg/saat continuous infusion)
Midazolam
0.2 mg/kg/saat continuous infusion of midazolam received during anaesthesia
Sevoflurane
Used for the maintenance for anaesthesia (% 0.5-8 end tidal concentration)
Sevoflurane
end tidal concentration of % 0,5-8
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midazolam
0.2 mg/kg/saat continuous infusion of midazolam received during anaesthesia
Sevoflurane
end tidal concentration of % 0,5-8
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients written informed consent for study participation
Exclusion Criteria
* History of myocarditis
* Renal failure
* Pulmonary embolism
* Hypothyroidism
1 Month
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huseyin Utku YILDIRIM
Anaesthesiology Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baskent University, Faculty of Medicine
Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA 11/60
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.